Hepatic histology in obese patients undergoing bariatric surgery

被引:412
作者
Machado, Mariana
Marques-Vidal, Pedro
Cortez-Pinto, Helena [1 ]
机构
[1] Univ Lisbon, Fac Med, IMM, Dept Gastroenterol, P-1699 Lisbon, Portugal
[2] Univ Lisbon, Fac Med, IMM, Unidade Nutr & Metab, P-1699 Lisbon, Portugal
关键词
non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; morbid obesity; bariatric surgery;
D O I
10.1016/j.jhep.2006.06.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Obesity is one of the most important clinical associations with non-alcoholic steatohepatitis (NASH). Our aim was to assess the prevalence of non-alcoholic fatty liver disease (NAFLD)/NASH in morbidly obese patients and the risk factors to more aggressive liver disease in this population. Methods: Review of available studies on prevalence of NAFLD/NASH in severely obese patients submitted to bariatric surgery. Results: Twelve observational and transversal studies were included, with consecutive recruitment, and prospective evaluation of data, summing 1620 patients with severe obesity. Prevalence of steatosis and NASH was 91% (range: 85-98%) and 37% (24-98%), respectively, with unexpected cirrhosis in 1.7% (1-7%). NASH was not related with age or body mass index, but there was an association between male sex and NASH/hepatic fibrosis. Diabetes mellitus and insulin resistance were the conditions most frequently associated with NASH, and hypertension with advanced hepatic fibrosis. Conclusions: There is a very high prevalence of NAFLD in asymptomatic morbidly obese patients, more than one-third presenting histological criteria for NASH. This review underscores the large variations in prevalence of NASH between studies, calling for the need for a better agreement in the use of the histological criteria. (c) 2006 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:600 / 606
页数:7
相关论文
共 37 条
[1]   Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease [J].
Abrams, GA ;
Kunde, SS ;
Lazenby, AJ ;
Clements, RH .
HEPATOLOGY, 2004, 40 (02) :475-483
[2]   Liver fibrosis [J].
Bataller, R ;
Brenner, DA .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :209-218
[3]   Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study [J].
Bedogni, G ;
Miglioli, L ;
Masutti, F ;
Tiribelli, C ;
Marchesini, G ;
Bellentani, S .
HEPATOLOGY, 2005, 42 (01) :44-52
[4]   Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery [J].
Beymer, C ;
Kowdley, KV ;
Larson, A ;
Edmonson, P ;
Dellinger, EP ;
Flum, DR .
ARCHIVES OF SURGERY, 2003, 138 (11) :1240-1244
[5]   Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass [J].
Boza, C ;
Riquelme, A ;
Ibañez, L ;
Duarte, I ;
Norero, E ;
Viviani, P ;
Soza, A ;
Fernandez, JI ;
Raddatz, A ;
Guzman, S ;
Arrese, M .
OBESITY SURGERY, 2005, 15 (08) :1148-1153
[6]   LIVER IN OBESITY [J].
BRAILLON, A ;
CAPRON, JP ;
HERVE, MA ;
DEGOTT, C ;
QUENUM, C .
GUT, 1985, 26 (02) :133-139
[7]   Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions [J].
Brunt, EM ;
Janney, CG ;
Di Bisceglie, AM ;
Neuschwander-Tetri, BA ;
Bacon, BR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) :2467-2474
[8]  
BRUNT EM, 2005, HEPATOL RES
[9]  
Chavarría-Arciniega S, 2005, REV INVEST CLIN, V57, P505
[10]   NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome [J].
Chitturi, S ;
Abeygunasekera, S ;
Farrell, GC ;
Holmes-Walker, J ;
Hui, JM ;
Fung, C ;
Karim, R ;
Lin, R ;
Samarasinghe, D ;
Liddle, C ;
Weltman, M ;
George, J .
HEPATOLOGY, 2002, 35 (02) :373-379